Epidermal growth factor enhances TNF-alpha-induced priming of human neutrophils

Immunol Lett. 2005 Jan 31;96(2):203-10. doi: 10.1016/j.imlet.2004.08.012.

Abstract

The intensity of neutrophil inflammatory response could be rapidly amplified by priming with pro-inflammatory mediators such as TNF-alpha, GM-CSF or LPS at low concentrations prior to stimuli. We proposed that epidermal growth factor (EGF) increases TNF-alpha-induced priming of human neutrophils. This study showed that EGF enhanced TNF-alpha-induced activation of neutrophils functions. The addition of EGF to neutrophils cultured with TNF-alpha resulted in increased respiratory burst and phagocytic activity of polymorphonuclear leukocytes (PMN) and up-regulation of adhesion molecule CD11b. Moreover, EGF enhanced IL-8 production by TNF-alpha-primed PMN. EGF alone was able to prime CD11b expression and IL-8 production by PMN. EGF receptor selective tyrosine kinase inhibitor, tyrphostin AG-1517, blocked the effect of priming with EGF, whereas the status of non-primed and TNF-alpha-primed neutrophils remained unaffected. EGFR expression on neutrophils was confirmed by flow cytometry and CELISA methods. These data provide the original evidence that EGF significantly enhances TNF-alpha-induced priming of human neutrophils acting through EGFR tyrosine kinase pathway. The observed effect may be a result of co-operative action of EGF, TNF-alpha and reactive oxygen intermediates (ROI).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD11b Antigen / metabolism
  • Cells, Cultured
  • Epidermal Growth Factor / pharmacology
  • Epidermal Growth Factor / physiology*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / physiology
  • Humans
  • Inflammation / metabolism
  • Interleukin-8 / metabolism
  • Neutrophils / drug effects
  • Neutrophils / immunology*
  • Phagocytosis / physiology*
  • Protein Kinase Inhibitors / pharmacology
  • Quinazolines / pharmacology
  • Reactive Oxygen Species / metabolism
  • Respiratory Burst / physiology*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / physiology*
  • Tyrphostins / pharmacology

Substances

  • AG 1517
  • CD11b Antigen
  • Interleukin-8
  • Protein Kinase Inhibitors
  • Quinazolines
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Tyrphostins
  • Epidermal Growth Factor
  • ErbB Receptors